https://www.pharmaradar360.com/article/f171945efe26209ePharmaRadar360en2026-05-04T13:03:52.000ZApós 30 anos, a Lei de Propriedade Industrial precisa evoluir, afirma presidente da Interfarmahttps://www.pharmaradar360.com/article/8810a9c11582abccPharmaRadar360en2026-05-04T12:25:44.000ZEU Innovation Network (EU IN)https://www.pharmaradar360.com/article/128b0ca31a9ae746PharmaRadar360en2026-05-04T10:59:00.000ZBristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026™https://www.pharmaradar360.com/article/fbff0213556eddffPharmaRadar360en2026-05-04T07:37:30.000ZLa AEMPS informa del cese de comercialización, retirada del mercado y recuperación de un lote del producto cosmético Suavinex Baby Cologne Memorieshttps://www.pharmaradar360.com/article/4c3a1fbd4fa6621fPharmaRadar360en2026-05-04T05:11:01.000ZΓενόσημα Ιανουαρίου 2026_Τελικές Προτεινόμενες Τιμέςhttps://www.pharmaradar360.com/article/10c07a1a16d0bafaPharmaRadar360en2026-05-04T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/1f949a91edc30087PharmaRadar360en2026-05-04T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/350a60c7b3e85302PharmaRadar360en2026-05-04T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/c8598068ea8127c0PharmaRadar360en2026-05-04T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/0a5e0308bd68fc85PharmaRadar360en2026-05-04T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/4b025667095a3bc1PharmaRadar360en2026-05-04T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/a11f3a5a577176c0PharmaRadar360en2026-05-04T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/35a834afcaf6c51cPharmaRadar360en2026-05-04T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/af91c0f6b417069bPharmaRadar360en2026-05-04T00:00:00.000Zlegal update regarding risdiplamhttps://www.pharmaradar360.com/article/a7acf68266af9c99PharmaRadar360en2026-05-04T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/6a46b0b882d871eePharmaRadar360en2026-05-04T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/8362892646c3eb4ePharmaRadar360en2026-05-04T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/af3a917d8774b2c2PharmaRadar360en2026-05-04T00:00:00.000Z6203https://www.pharmaradar360.com/article/ec2f05b5d177765aPharmaRadar360en2026-05-04T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/9d5ea789e348ce1dPharmaRadar360en2026-05-04T00:00:00.000ZCleveland Clinic Children’s Unveils Program to Expand Access to Pediatric Mental Health Care